Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
ACS Applied Materials & Interfaces|July 3, 2024
Tungsten-Doped ZnO as an Electron Transport Layer for Perovskite Solar Cells: Enhancing Efficiency and StabilityMunkhtuul Gantumur, Mohammad Ismail Hossain, Md Shahiduzzaman, et al.
Thrombosis Research|February 22, 2024
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemiaGiovangiacinto Paterno, Raffaele Palmieri, Cristiano Tesei, et al.
Current Research in Translational Medicine|January 26, 2024
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare T-cell lymphoma: A clinical challengeAndrea Nunzi, Giulia Ciangola, Ilaria Cerroni, et al.
Breast Cancer Research and Treatment|December 24, 2013
Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2J Thaddeus Beck, Gabriel N Hortobagyi, Mario Campone, et al.
Infection and Immunity|March 21, 2022
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche DeterminantsClaudio Costantini, Emilia Nunzi, Angelica Spolzino, et al.
Tumori|June 6, 2015
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrenceGiuseppe Bogina, Gianluigi Lunardi, Francesca Coati, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 10, 2024
Acute Leukemia and Latent Tuberculosis Infection in Italy: Quantiferon-Tb Test Screening in a Low Tuberculosis Incidence CountryAndrea Nunzi, Luigi Della Valle, Elisa Linnea Lindfors Rossi, et al.
Current Medical Research and Opinion|August 22, 2013
Health-related quality of life and disease symptoms in postmenopausal women with HR(+), HER2(-) advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapyMario Campone, J Thaddeus Beck, Michael Gnant, et al.
Breast Cancer Research : BCR|October 29, 2022
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER studyNicla La Verde, Giovanna Damia, Ornella Garrone, et al.
American Journal of Respiratory Cell and Molecular Biology|October 17, 2022
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic FibrosisMarilena Pariano, Matteo Puccetti, Claudia Stincardini, et al.
Pageof 26